Werner Cautreels's Insider Trades & SAST Disclosures
Werner Cautreels's most recent trade in Traws Pharma Inc. was a trade of 96,348 Common Stock done at an average price of $0.0 . Disclosure was reported to the exchange on Feb. 18, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Werner Cautreels.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Traws Pharma Inc. | Werner Cautreels | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.01 per share. | 18 Feb 2025 | 96,348 | 104,348 (0%) | 0% | 0.0 | 963 | Common Stock |
| Traws Pharma Inc. | Werner Cautreels | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 96,348 | 0 | - | - | Pre-Funded Warrant (right to buy) | |
| Traws Pharma Inc. | Werner Cautreels | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 29 Dec 2024 | 96,348 | 96,348 | - | - | Series A Warrant (right to buy) | |
| Traws Pharma Inc. | Werner Cautreels | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 29 Dec 2024 | 96,348 | 96,348 | - | - | Pre-Funded Warrant (right to buy) | |
| Traws Pharma Inc. | Werner Cautreels | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 200,000 | 200,000 (0%) | 0% | - | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges